Searched over 200M research papers
10 papers analyzed
These studies suggest that lisinopril can cause angioedema, including lip swelling, which may resolve upon discontinuation of the medication or require specific treatments like icatibant.
20 papers analyzed
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely prescribed for managing hypertension and heart failure. However, a significant adverse effect associated with ACE inhibitors, including lisinopril, is angioedema, which can manifest as swelling of the lips, face, tongue, and other areas .
The primary mechanism behind lisinopril-induced angioedema involves the accumulation of bradykinin, a peptide that causes blood vessels to dilate and become more permeable. ACE inhibitors decrease the metabolism of bradykinin, leading to its buildup and subsequent swelling . This reaction can occur even after years of stable therapy with lisinopril .
Patients typically present with sudden onset of swelling in the lips, face, or tongue. This swelling can be painless and non-itchy, and it may or may not be accompanied by respiratory distress . In some cases, the swelling can progress to involve the throat, leading to potential airway obstruction and requiring immediate medical attention .
Several case studies highlight the variability in presentation and severity of lisinopril-induced angioedema:
The immediate management of lisinopril-induced angioedema involves discontinuing the offending drug and administering corticosteroids and antihistamines to reduce inflammation and swelling . In severe cases, where there is significant airway involvement, more aggressive interventions such as intubation or the use of bradykinin receptor antagonists like icatibant may be necessary .
Patients who experience angioedema due to lisinopril should avoid all ACE inhibitors in the future to prevent recurrence. Alternative antihypertensive medications, such as angiotensin II receptor blockers (ARBs), may be considered as they have a lower risk of causing angioedema .
Lisinopril-induced angioedema is a serious but manageable condition. Awareness of its clinical presentation and prompt discontinuation of the drug are crucial for effective management. Healthcare providers should educate patients on the potential risks and ensure close monitoring, especially after procedures or trauma involving the head and neck.
Most relevant research papers on this topic